166 related articles for article (PubMed ID: 21179035)
1. Toll-like receptor 2 is present in the microenvironment of oral squamous cell carcinoma.
Ng LK; Rich AM; Hussaini HM; Thomson WM; Fisher AL; Horne LS; Seymour GJ
Br J Cancer; 2011 Feb; 104(3):460-3. PubMed ID: 21179035
[TBL] [Abstract][Full Text] [Related]
2. Expanded Expression of Toll-Like Receptor 2 in Proliferative Verrucous Leukoplakia.
Koh J; Kurago ZB
Head Neck Pathol; 2019 Dec; 13(4):635-642. PubMed ID: 30888638
[TBL] [Abstract][Full Text] [Related]
3. Differential immunohistochemical expression profiles of perlecan-binding growth factors in epithelial dysplasia, carcinoma in situ, and squamous cell carcinoma of the oral mucosa.
Hasegawa M; Cheng J; Maruyama S; Yamazaki M; Abé T; Babkair H; Saito C; Saku T
Pathol Res Pract; 2016 May; 212(5):426-36. PubMed ID: 26965914
[TBL] [Abstract][Full Text] [Related]
4. Distribution and synthesis of type VII collagen in oral squamous cell carcinoma.
Kainulainen T; Grenman R; Oikarinen A; Greenspan DS; Salo T
J Oral Pathol Med; 1997 Oct; 26(9):414-8. PubMed ID: 9385579
[TBL] [Abstract][Full Text] [Related]
5. Alterations of collagen XVII expression during transformation of oral epithelium to dysplasia and carcinoma.
Parikka M; Kainulainen T; Tasanen K; Väänänen A; Bruckner-Tuderman L; Salo T
J Histochem Cytochem; 2003 Jul; 51(7):921-9. PubMed ID: 12810842
[TBL] [Abstract][Full Text] [Related]
6. [Expression of integrin-linked kinase in oral leukoplakia and early invasive carcinoma].
Guo ZL; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Mar; 45(3):163-7. PubMed ID: 20450685
[TBL] [Abstract][Full Text] [Related]
7. Immunolocalization of c-Jun in normal mucosa, oral submucous fibrosis, epithelial dysplasia, and oral squamous cell carcinoma: A comparative study.
Shraddha KS; Niranjan KC; Hallikeri K
J Cancer Res Ther; 2018; 14(6):1180-1183. PubMed ID: 30488826
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor κB and cyclooxygenase-2 immunoexpression in oral dysplasia and oral squamous cell carcinoma.
Pontes HA; Pontes FS; Fonseca FP; de Carvalho PL; Pereira EM; de Abreu MC; de Freitas Silva BS; dos Santos Pinto D
Ann Diagn Pathol; 2013 Feb; 17(1):45-50. PubMed ID: 22818026
[TBL] [Abstract][Full Text] [Related]
9. Expression of p63 protein and mRNA in oral epithelial dysplasia.
Chen YK; Hsue SS; Lin LM
J Oral Pathol Med; 2005 Apr; 34(4):232-9. PubMed ID: 15752259
[TBL] [Abstract][Full Text] [Related]
10. Suprabasal expression of Ki-67 antigen as a marker for the presence and severity of oral epithelial dysplasia.
Gonzalez-Moles MA; Ruiz-Avila I; Rodriguez-Archilla A; Martinez-Lara I
Head Neck; 2000 Oct; 22(7):658-61. PubMed ID: 11002319
[TBL] [Abstract][Full Text] [Related]
11. Expression profile of drosomycin-like defensin in oral epithelium and oral carcinoma cell lines.
Sato J; Nishimura M; Yamazaki M; Yoshida K; Kurashige Y; Saitoh M; Abiko Y
Arch Oral Biol; 2013 Mar; 58(3):279-85. PubMed ID: 23084467
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma.
Kerdpon D; Rich AM; Reade PC
Oral Dis; 1997 Jun; 3(2):86-92. PubMed ID: 9467348
[TBL] [Abstract][Full Text] [Related]
13. Increased nuclear β-catenin expression in oral potentially malignant lesions: A marker of epithelial dysplasia.
Reyes M; Rojas-Alcayaga G; Maturana A; Aitken JP; Rojas C; Ortega AV
Med Oral Patol Oral Cir Bucal; 2015 Sep; 20(5):e540-6. PubMed ID: 26241451
[TBL] [Abstract][Full Text] [Related]
14. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 2 activation implicated in oral squamous cell carcinoma development.
Ikehata N; Takanashi M; Satomi T; Watanabe M; Hasegawa O; Kono M; Enomoto A; Chikazu D; Kuroda M
Biochem Biophys Res Commun; 2018 Jan; 495(3):2227-2234. PubMed ID: 29269299
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Potential of N-Cadherin in Oral Squamous Cell Carcinoma via Immunohistochemical Methods.
Chandolia B; Rajliwal JP; Bajpai M; Arora M
J Coll Physicians Surg Pak; 2017 Aug; 27(8):475-478. PubMed ID: 28903838
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.
Abrahao AC; Bonelli BV; Nunes FD; Dias EP; Cabral MG
Braz Oral Res; 2011; 25(1):34-41. PubMed ID: 21359449
[TBL] [Abstract][Full Text] [Related]
18. Deregulated Bag-1 protein expression in human oral squamous cell carcinomas and lymph node metastases.
Hague A; Packham G; Huntley S; Shefford K; Eveson JW
J Pathol; 2002 May; 197(1):60-71. PubMed ID: 12081206
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of heat shock protein 27 in normal oral mucosa, oral epithelial dysplasia and squamous cell carcinoma.
Leonardi R; Pannone G; Magro G; Kudo Y; Takata T; Lo Muzio L
Oncol Rep; 2002; 9(2):261-6. PubMed ID: 11836590
[TBL] [Abstract][Full Text] [Related]
20. Lack of elevated HER2/neu expression in epithelial dysplasia and oral squamous cell carcinoma in Iran.
Seifi S; Shafaei SN; Nosrati K; Ariaeifar B
Asian Pac J Cancer Prev; 2009; 10(4):661-4. PubMed ID: 19827890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
